The global genomics market size is calculated at USD 44.21 billion in 2025 and is forecasted to reach around USD 175.18 billion by 2034, accelerating at a CAGR of 16.53% from 2025 to 2034. The North America genomics market size surpassed USD 14.39 billion in 2024 and is expanding at a CAGR of 16.54% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Genomics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Genomics Market, by Product and Services
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast
8.1.2. Systems and Software
8.1.2.1. Market Revenue and Forecast
8.1.3. Services Equipment
8.1.3.1. Market Revenue and Forecast
9.1. Genomics Market, by Technology
9.1.1. PCR (Polymerase Chain Reaction)
9.1.1.1. Market Revenue and Forecast
9.1.2. Sequencing
9.1.2.1. Market Revenue and Forecast
9.1.3. Microarray
9.1.3.1. Market Revenue and Forecast
9.1.4. Nucleic Acid Extraction and Purification
9.1.4.1. Market Revenue and Forecast
9.1.5. Other Technologies (Branched DNA Analysis, Single-cell Genomics Analysis, and Flow Cytometry)
9.1.5.1. Market Revenue and Forecast
10.1. Genomics Market, by Application
10.1.1. Drug Discovery and Development
10.1.1.1. Market Revenue and Forecast
10.1.2. Diagnostics
10.1.2.1. Market Revenue and Forecast
10.1.3. Precision Medicine
10.1.3.1. Market Revenue and Forecast
10.1.4. Agriculture and Animal Research
10.1.4.1. Market Revenue and Forecast
10.1.5. Other Applications
10.1.5.1. Market Revenue and Forecast
11.1. Genomics Market, by End-Users
11.1.1. Hospitals & Clinics
11.1.1.1. Market Revenue and Forecast
11.1.2. Research Centers and Academic & Government Institutes
11.1.2.1. Market Revenue and Forecast
11.1.3. Pharmaceutical & Biotechnology Companies
11.1.3.1. Market Revenue and Forecast
11.1.4. Other End-users
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product and Services
12.1.2. Market Revenue and Forecast, by Technology
12.1.3. Market Revenue and Forecast, by Application
12.1.4. Market Revenue and Forecast, by End-Users
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product and Services
12.1.5.2. Market Revenue and Forecast, by Technology
12.1.5.3. Market Revenue and Forecast, by Application
12.1.5.4. Market Revenue and Forecast, by End-Users
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product and Services
12.1.6.2. Market Revenue and Forecast, by Technology
12.1.6.3. Market Revenue and Forecast, by Application
12.1.6.4. Market Revenue and Forecast, by End-Users
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product and Services
12.2.2. Market Revenue and Forecast, by Technology
12.2.3. Market Revenue and Forecast, by Application
12.2.4. Market Revenue and Forecast, by End-Users
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product and Services
12.2.5.2. Market Revenue and Forecast, by Technology
12.2.5.3. Market Revenue and Forecast, by Application
12.2.5.4. Market Revenue and Forecast, by End-Users
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product and Services
12.2.6.2. Market Revenue and Forecast, by Technology
12.2.6.3. Market Revenue and Forecast, by Application
12.2.6.4. Market Revenue and Forecast, by End-Users
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product and Services
12.2.7.2. Market Revenue and Forecast, by Technology
12.2.7.3. Market Revenue and Forecast, by Application
12.2.7.4. Market Revenue and Forecast, by End-Users
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product and Services
12.2.8.2. Market Revenue and Forecast, by Technology
12.2.8.3. Market Revenue and Forecast, by Application
12.2.8.4. Market Revenue and Forecast, by End-Users
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product and Services
12.3.2. Market Revenue and Forecast, by Technology
12.3.3. Market Revenue and Forecast, by Application
12.3.4. Market Revenue and Forecast, by End-Users
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product and Services
12.3.5.2. Market Revenue and Forecast, by Technology
12.3.5.3. Market Revenue and Forecast, by Application
12.3.5.4. Market Revenue and Forecast, by End-Users
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product and Services
12.3.6.2. Market Revenue and Forecast, by Technology
12.3.6.3. Market Revenue and Forecast, by Application
12.3.6.4. Market Revenue and Forecast, by End-Users
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product and Services
12.3.7.2. Market Revenue and Forecast, by Technology
12.3.7.3. Market Revenue and Forecast, by Application
12.3.7.4. Market Revenue and Forecast, by End-Users
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product and Services
12.3.8.2. Market Revenue and Forecast, by Technology
12.3.8.3. Market Revenue and Forecast, by Application
12.3.8.4. Market Revenue and Forecast, by End-Users
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product and Services
12.4.2. Market Revenue and Forecast, by Technology
12.4.3. Market Revenue and Forecast, by Application
12.4.4. Market Revenue and Forecast, by End-Users
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product and Services
12.4.5.2. Market Revenue and Forecast, by Technology
12.4.5.3. Market Revenue and Forecast, by Application
12.4.5.4. Market Revenue and Forecast, by End-Users
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product and Services
12.4.6.2. Market Revenue and Forecast, by Technology
12.4.6.3. Market Revenue and Forecast, by Application
12.4.6.4. Market Revenue and Forecast, by End-Users
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product and Services
12.4.7.2. Market Revenue and Forecast, by Technology
12.4.7.3. Market Revenue and Forecast, by Application
12.4.7.4. Market Revenue and Forecast, by End-Users
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product and Services
12.4.8.2. Market Revenue and Forecast, by Technology
12.4.8.3. Market Revenue and Forecast, by Application
12.4.8.4. Market Revenue and Forecast, by End-Users
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product and Services
12.5.2. Market Revenue and Forecast, by Technology
12.5.3. Market Revenue and Forecast, by Application
12.5.4. Market Revenue and Forecast, by End-Users
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product and Services
12.5.5.2. Market Revenue and Forecast, by Technology
12.5.5.3. Market Revenue and Forecast, by Application
12.5.5.4. Market Revenue and Forecast, by End-Users
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product and Services
12.5.6.2. Market Revenue and Forecast, by Technology
12.5.6.3. Market Revenue and Forecast, by Application
12.5.6.4. Market Revenue and Forecast, by End-Users
13.1. Thermo Fisher Scientific, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Illumina, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Oxford Nanopore Technologies
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. QIAGEN N.V.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. BGI
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Eurofins Scientific
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. GE Healthcare
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Agilent Technologies, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Bio-Rad Laboratories, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Hoffmann-La Roche Ltd.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample